Compression and CO2 Laser for Leg Wounds
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Compression bandages, Standard wound dressings, Fractional ablative carbon dioxide laser.
- Who it may be relevant to
- Registry conditions: Wound Healing. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Randomized, Investigator-blinded Study of Compression in Wound Healing With and Without Fractional Ablative CO2 Laser After Excisions on the Lower Extremity (CHIME+)
Overview
The purpose of this study is to determine the efficacy and safety of compression bandaging with fractional ablative carbon dioxide laser (FACL) compared to compression and standard dressings alone for healing of post-operative wounds of the leg. This is a randomized, SMART design, clinical trial. Approximately 80 participants will be randomized to initially receive compression bandages or standard wound dressings after surgery on the lower leg. After 4 weeks, the group assigned to compression bandages will be further randomized to either continue with the compression bandages only or continue with the compression bandages and also receive (FACL). The study is designed as an 6-month study. This study was a pilot study designed to determine feasibility of these procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Interventions
- Other Compression bandages
Class I (20-30 mmHg) compression bandages or stocking - Other Standard wound dressings
Wound dressings alone consisting of gauze and skin tape to cover the wound - Device Fractional ablative carbon dioxide laser
Participant will have laser applied to their wound bed.
Primary outcome measures
- Mean change wound size as determined by measurements [Time frame: Baseline to 6 months]
Eligibility criteria
Inclusion Criteria:Patients will be identified through the clinic where their skin is to be treated by excisional surgery on the lower leg. Those considered for enrollment must also meet the following criteria:
- >18 years of age
- Wound size of at least 1 cm in width
- Cutaneous excision of the lower leg
- Surgeon elected repair of healing by secondary intention
- Participants must have the ability to understand and the willingness to sign a written informed consent prior to registration on study
Exclusion criteria
- Current smoker
- Uncontrolled diabetes mellitus
- Uncontrolled hypothyroidism
- Severe renal impairment or hypoalbuminemia
- Chronic lymphedema
- Severe venous insufficiency (large varicose veins, atrophie blanche)
- Arterial insufficiency (ABI < 0.8)
- Rubber or rubber accelerator allergy
- Prior radiation to the surgical site
- History or evidence of a clinically significant medical or psychiatric disorder, condition or disease that in the opinion of the treating physician would pose a risk or interfere with evaluation or completion of the study
- Subject un willing to sign an IRB approved consent form
- Participants who are unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function are not eligible
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Northwestern University Department of Dermatology — Chicago
Identifiers
NCT: NCT04198454 · STU00211239